user

The EMI study: A regional feasibility study for a randomised trial of adjuvant chemotherapy following definitive treatment for transitional cell cancer (TCC) of the bladder.

被引：0
|
作者：
Leahy, MG
Brown, J
Jones, WG
Kelly, J
Neal, DE
Prescott, S
Roberts, T
Selby, P
机构：
[1] Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England
[2] Leeds Canc Ctr, Leeds, W Yorkshire, England
[3] Univ Newcastle, Newcastle Upon Tyne, Tyne & Wear, England
[4] Leeds Teaching Hosps NHS Trust, Leeds, W Yorkshire, England
[5] Canc Res UK, Ctr Clin, Leeds, W Yorkshire, England
来源：
BRITISH JOURNAL OF CANCER | 2002年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S3 / S3
页数：1
相关论文
共 50 条
  • [21] Combination chemotherapy with cis-platin (CDDP), epirubicin (EPI), and docetaxel (DDC) in transitional cell urothelial cancer (TCC). A phase II study
    Pectasides, D
    Visvikis, A
    Aspropotamitis, A
    Halikia, A
    Kalantaridou, A
    Batzios, S
    Karvounis, N
    Athanassiou, A
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S348 - S348
  • [22] A randomised study evaluating maintenance schedule in early adjuvant chemotherapy for intermediate risk non-muscle-invasive bladder cancer
    Serretta, V.
    Altieri, V.
    Morgia, G.
    Annese, P.
    Carried, G.
    Zito, A.
    Di Lallo, A.
    Ruggiero, G.
    Salzano, L.
    Nicolosi, F.
    Simone, N. S.
    Vacirca, F.
    Pavone-Macaluso, M.
    Selvaggi, F. P.
    Coraci, G.
    Allegro, R.
    Melloni, D.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 298 - 298
  • [23] Feasibility study of alternate-day S-1 as adjuvant chemotherapy for gastric cancer: a randomized controlled trial
    Shigeru Tatebe
    Shunichi Tsujitani
    Seiichi Nakamura
    Tetsu Shimizu
    Nariyuki Yamane
    Hideaki Nishidoi
    Yasuro Kurisu
    Hirotomo Kanayama
    Haruaki Ogawa
    Masahide Ikeguchi
    [J]. Gastric Cancer, 2014, 17 : 508 - 513
  • [24] Feasibility study of alternate-day S-1 as adjuvant chemotherapy for gastric cancer: a randomized controlled trial
    Tatebe, Shigeru
    Tsujitani, Shunichi
    Nakamura, Seiichi
    Shimizu, Tetsu
    Yamane, Nariyuki
    Nishidoi, Hideaki
    Kurisu, Yasuro
    Kanayama, Hirotomo
    Ogawa, Haruaki
    Ikeguchi, Masahide
    [J]. GASTRIC CANCER, 2014, 17 (03) : 508 - 513
  • [25] ADJUVANT CHEMOTHERAPY FOLLOWING RADICAL SURGERYFOR NON-SMALL CELL LUNG CANCER:A RANDOMIZED STUDY
    徐光川
    戎铁华
    林鹏
    [J]. Chinese Journal of Cancer Research, 1999, (01) : 3 - 5
  • [26] Tumor Location May Predict Adverse Pathology and Survival Following Definitive Treatment for Bladder Cancer: A National Cohort Study
    Weiner, Adam B.
    Desai, Anuj S.
    Meeks, Joshua J.
    [J]. EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (03): : 304 - 310
  • [27] Efficacy of Adjuvant Gemcitabine-Cisplatin Chemotherapy: A Comparative Study between Locally Advanced Transitional Cell Carcinoma of the Bladder and Upper Urinary Tract
    Song, Yun Seob
    Cho, Jin Seon
    Cho, Kang Su
    Doo, Seung Hwan
    Chung, Byung Ha
    Kim, Se Joong
    Yang, Won Jae
    Song, Ki Hak
    Kim, Chun Il
    Hong, Sung Joon
    [J]. UROLOGIA INTERNATIONALIS, 2010, 85 (01) : 47 - 51
  • [28] Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: Long-term results of a European organization for research and treatment of cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection alone
    Kurth, K
    Tunn, U
    Ay, R
    Schroder, FH
    PavoneMacaluso, M
    Debruyne, F
    TenKate, F
    DePauw, M
    Sylvester, R
    Essed, E
    Caubergh, RV
    Hoekstra, JW
    deVoogt, HJ
    Newling, DWW
    deReijke, TM
    Mensink, HJA
    Groen, JM
    Jakse, G
    Leisinger, HJ
    Richards, B
    Adib, RA
    Robinson, M
    Denis, L
    Bouffioux, C
    Schulman, C
    Carpentier, PJ
    [J]. JOURNAL OF UROLOGY, 1997, 158 (02): : 378 - 384
  • [29] Trial of Optimal Personalised Care After Treatment for Gynaecological cancer (TOPCAT-G): A study protocol for a randomised feasibility trial
    Pye K.
    Totton N.
    Stuart N.
    Whitaker R.
    Morrison V.
    Edwards R.T.
    Yeo S.T.
    Timmis L.J.
    Butterworth C.
    Hall L.
    Rai T.
    Hoare Z.
    Neal R.D.
    Wilkinson C.
    Leeson S.
    [J]. Pilot and Feasibility Studies, 2 (1)
  • [30] PHASE II RANDOMISED TRIAL OF NEO-ADJUVANT CHEMOTHERAPY (NACT) FOLLOWED BY CHEMORADIATION VS CHEMORADIATION ALONE IN LOCALLY ADVANCED HEAD AND NECK CANCER (HNC). A FEASIBILITY STUDY
    Merlano, Marco
    Colantonio, Ida
    Numico, Gianmauro
    Garrone, Ornella
    Granetto, Cristina
    Gasco, Milena
    Di Costanzo, Gianna
    Heouaine, Abdelhamid
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 36 - 36
12345